6640--Cost-Per-Test RT-PCR RSV Infections RFQ 36C25225Q0249 Posted Sources Sought under 36C25225Q0226

The Department of Veterans Affairs Veterans Health Administration is seeking FDA-approved or EUA-authorized, CLIA-waived rapid PCR-based point of care analyzers and assays for simultaneous detection of SARS-CoV-2, RSV, and Influenza A & B viruses in nasal swab specimens. This solicitation, identified as RFQ 36C25225Q0249, requires instruments with specific technical capabilities including a compact one cubic foot footprint, 30-minute result production, and interface compatibility with RALS middleware and VA electronic health records. The VA will evaluate quotes using a comparative process that considers both technical capability and price, with the flexibility to select a quote that provides additional benefits beyond the lowest price. The solicitation is unrestricted under NAICS code 334516 with a size standard of 1,000 employees. Interested vendors must submit their responses by February 21, 2025, at 12:00 CST.

The contract will be a single-award, firm-fixed price Indefinite Delivery/Indefinite Quantity (IDIQ) agreement with five one-year ordering periods. The minimum contract guarantee is $50,000, with a maximum ceiling amount of $800,000. Eight instruments will be deployed to VA facilities located in Michigan and Wisconsin, focusing on point-of-care diagnostic testing capabilities. The procurement requires vendors to provide analyzers with minimal sample manipulation requirements and secure data management features. This solicitation represents a significant opportunity for manufacturers of analytical laboratory instruments to support critical healthcare diagnostics within the Veterans Health Administration network, with potential for substantial recurring revenue through the multi-year contract structure.